These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bisphosphonates and avascular necrosis of alveolar bone: a potential threat to dental implants. Garg AK Dent Implantol Update; 2006 Oct; 17(10):73-8. PubMed ID: 17066981 [No Abstract] [Full Text] [Related]
6. Pharmacological treatment of osteonecrosis. Aspenberg P Acta Orthop; 2006 Apr; 77(2):175-6. PubMed ID: 16752277 [No Abstract] [Full Text] [Related]
7. Bisphosphonates and glucocorticoids: effects on bone quality. Lems WF Arthritis Rheum; 2007 Nov; 56(11):3518-22. PubMed ID: 17968935 [No Abstract] [Full Text] [Related]
8. Slumbering time-bomb. Dean F Br Dent J; 2006 Sep; 201(5):249. PubMed ID: 16960582 [No Abstract] [Full Text] [Related]
9. [Treatment of bone metastases with bisphosphonates]. Gremaud M; Delouche D; Monnerat C Rev Med Suisse; 2006 Aug; 2(75):1861-6. PubMed ID: 16948423 [TBL] [Abstract][Full Text] [Related]
10. Warning: bisphosphonates and osteochemonecrosis of the jaws. Flint SR; Sharkey S; Galvin S J Ir Dent Assoc; 2006; 52(2):79-83. PubMed ID: 16989369 [TBL] [Abstract][Full Text] [Related]
11. Osteoporosis in men. Joy M N Engl J Med; 2008 Aug; 359(8):868; author reply 869. PubMed ID: 18724403 [No Abstract] [Full Text] [Related]
12. Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis. Med Lett Drugs Ther; 2009 Jun; 51(1315):49. PubMed ID: 19556940 [No Abstract] [Full Text] [Related]
13. Effect of zoledronic acid on bone pain secondary to metastatic bone disease. Rotjanapan P Med Health R I; 2009 Jan; 92(1):27-9. PubMed ID: 19248423 [No Abstract] [Full Text] [Related]
19. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma. Migliorati CA; Hsu CJ; Chopra S; Kaltman SS J Calif Dent Assoc; 2008 Oct; 36(10):769-74. PubMed ID: 19044097 [TBL] [Abstract][Full Text] [Related]
20. The role of nurses in preserving patients' functional independence: Zoledronic acid--evidence and experience in metastatic bone disease. Fitch MI Eur J Oncol Nurs; 2007; 11 Suppl 2():S27. PubMed ID: 17804295 [No Abstract] [Full Text] [Related] [Next] [New Search]